Inventor
BURKHARD LUDEWIG
Inventor
CH
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C12NMicroorganisms or enzymes26%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms21%
Y02ATechnologies for adaptation to climate change21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations5%
PatentTitleYear
11,690,880Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202311,617,773Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy202311,534,467Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202211,376,286Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202211,224,621Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to ELIGO BIOSCIENCE (5)· patent assignee history
2022–2023Based in CH· patent location history
2023Patents assigned to ST GALLEN KANTONSSPITAL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ELIGO BIOSCIENCE | 5 | 2022–2023 |
| ST GALLEN KANTONSSPITAL | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 5 | 2022–2023 |